Steroids versus standard heart medications for heart inflammation
Treatments studied
Part of Heart & circulation, Immune system & allergy clinical trials.
This study compares two treatment strategies for people with unexplained heart failure and irregular heartbeats caused by inflammation: one group gets standard heart medications plus an immune-suppressing steroid (prednisone), and the other gets standard medications alone. Doctors want to see whether adding steroids helps improve heart function and control dangerous heart rhythms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have been diagnosed with heart failure (New York Heart Association class II, III, or stable class IV).
- Your heart's pumping strength (LVEF) is below 50% on an echocardiogram or similar test.
- You have had episodes of dangerously fast heart rhythms (sustained VT lasting more than 30 seconds).
- A PET scan has confirmed inflammation in your heart muscle (myocarditis).
- You have used steroids (like prednisone) within the last 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug colchicine can help people with heart muscle inflammation (myocarditis) that also causes abnormal heart rhythms, a weak heart pump, or high stress markers. Colchicine is an anti-inflammatory medicine that might reduce heart damage and improve symptoms.
This trial tests whether a course of steroid medicine can improve outcomes in people with recently started myocarditis (heart muscle inflammation) and mildly reduced heart pumping. It compares steroids versus placebo (inactive treatment) to see if steroids help the heart recover and prevent worsening.
This trial tests if corticosteroids (steroids) help people with acute myocarditis, a sudden inflammation of the heart muscle. It aims to improve heart function and reduce symptoms like chest pain or heart failure.
This trial tests if a steroid medicine can help people with cardiogenic shock from heart failure who have high inflammation levels. It aims to see if reducing inflammation improves recovery.
This study tests whether steroid medicine helps people hospitalized with suspected acute myocarditis (inflammation of the heart). Participants are randomly assigned to receive steroids or a placebo, and the trial looks at outcomes after the acute episode starts.
This trial tests if high-dose steroids and/or immunoglobulins (antibody treatments) help people with sudden, severe heart inflammation (fulminant myocarditis) that causes shock or dangerous heart rhythms. The goal is to see which treatment or combination reduces heart damage and improves recovery.
Hear when a new Ventricular Arrythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.